new guidelines for monitoring patients on atypical antipsychotics

March 2004

Finally, there are new guidelines for monitoring patients on atypical antipsychotics...Risperdal, Zyprexa, Seroquel, etc.

These newer antipsychotics are sometimes more effective...and cause fewer movement disorders than the older antipsychotics.

But the atypicals have their own set of potentially serious adverse effects...obesity, diabetes, and dyslipidemia.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote